Myriam Chalabi: Juan O’Connor putting NEST-1 and ECOG /study into perspective

Myriam Chalabi shared on X:

“Great discussion by Juan OConnor in the mini-oral session ESMOGI24. Putting NEST-1 and ECOG /study into perspective. Also for highlighting our TARZAN trial with atezo/bev in rectal cancer for organ preservation (42% OP rate in 38 pMMR patients).“.

Source: Myriam Chalabi/X

Myriam Chalabi is a Gastrointestinal Oncologist and clinician scientist at the Netherlands Cancer Institute in Amsterdam. In 2022 she was named one of the 11 early career researchers to watch by Nature Medicine. In 2023 she was awarded the ESMO José Baselga Fellowship for Clinician Scientists.